🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Merit Medical Systems stock hits all-time high of $101.61

Published 11/07/2024, 01:12 AM
MMSI
-

Merit Medical Systems Inc. (NASDAQ:MMSI) has reached an all-time high, with its stock price soaring to $101.61. This milestone reflects a significant surge in the company's market value, marking a remarkable 41.43% increase over the past year. Investors have shown growing confidence in Merit Medical (TASE:PMCN) Systems, a leading manufacturer of disposable medical devices, as the company continues to expand its product portfolio and strengthen its global presence. The all-time high represents a culmination of sustained growth, driven by strategic acquisitions and a focus on innovation within the healthcare sector.

In other recent news, Merit Medical Systems Inc. reported strong growth for the third quarter, with total revenue reaching $339.8 million, a 7.8% increase on a GAAP basis and a 7.9% increase on a constant currency basis from the previous year. The company's non-GAAP operating profit also saw a 19% rise, achieving a non-GAAP operating margin of 19.2%. Additionally, free cash flow significantly increased to $38 million for the quarter and over $120 million for the year-to-date, representing a 116% increase year-over-year.

In other developments, Merit Medical is set to acquire Cook Medical's lead management portfolio, which is expected to generate significant revenue in the coming years. The company's updated financial guidance includes a GAAP net revenue growth forecast of 6.9% to 7.6% for 2024. However, supply chain challenges that could impact Q4 2023 were acknowledged, especially related to Baxter (NYSE:BAX) IV procedures.

Furthermore, the company raised its free cash flow expectation for 2024 to approximately $150 million. The management team, including CEO Fred Lampropoulos, CFO Raul Parra, President Joe Wright, and Chief Legal Officer Brian Lloyd, expressed confidence in their strategy and the future of their products, particularly the WRAPSODY program. This program has shown positive trial results and preparations for FDA approval indicate potential market growth.

InvestingPro Insights

Merit Medical Systems Inc.'s (MMSI) recent all-time high of $101.61 is further supported by InvestingPro data, which shows the stock trading at 99.81% of its 52-week high. This impressive performance is reflected in the company's strong financial metrics, with revenue reaching $1.33 billion in the last twelve months as of Q3 2023, representing an 8.12% growth. The company's profitability is evident, with a gross profit margin of 46.83% and an operating income margin of 11.51% for the same period.

InvestingPro Tips highlight that MMSI has been profitable over the last twelve months and is expected to remain profitable this year, aligning with the company's strong market performance. Additionally, the stock has demonstrated high returns over the last decade and strong returns over the past five years, supporting the long-term growth narrative mentioned in the article.

It's worth noting that MMSI operates with a moderate level of debt and its liquid assets exceed short-term obligations, indicating financial stability. However, investors should be aware that the stock is trading at a high P/E ratio of 48.79, which may suggest a premium valuation.

For readers interested in a more comprehensive analysis, InvestingPro offers 10 additional tips for MMSI, providing deeper insights into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.